Insempra's Innovative Approach to Sustainable Ingredients Secures $20 Million in Funding

May 11, 2024, 3:37 am
Insempra
Insempra
BioTechMaterialsPlatformProductProductionResearchTechnology
Location: Germany, Bavaria, Munich
Employees: 11-50
Founded date: 2021
Total raised: $20M
Insempra, a pioneering biotechnology company headquartered in Munich, Germany, recently announced the successful closure of a $20 million Series A financing round. This significant milestone marks a pivotal moment in the company's journey towards revolutionizing the sustainable ingredients industry.

Founded and led by CEO Jens Klein, Insempra is at the forefront of a regenerative revolution, enabling businesses across various sectors such as beauty & personal care, food & nutrition, and fashion to transition towards a more sustainable future. By harnessing the power of biotechnology, Insempra is dedicated to creating high-performance, intrinsically sustainable ingredients that are superior in quality and environmentally friendly.

The recent funding round saw participation from a diverse group of investors, including EQT Ventures, BlueYard Capital, Possible Ventures, Taavet Sten, Acequia Capital, Henkel dx Ventures, Bayern Kapital, and Alante Capital. These investors have recognized the potential of Insempra's market-first approach and innovative technology platforms, which aim to reduce our dependency on chemical industrialization processes.

Insempra's core mission revolves around working in harmony with nature to develop bio-based alternatives to traditional materials and chemicals. The company's cutting-edge technology platforms allow for the creation of new natural molecules that can be used in functional ingredients such as antioxidants, preservatives, flavors, and fragrances. By leveraging atomic precision in manufacturing processes, Insempra is able to rapidly produce and scale these ingredients, offering a sustainable alternative to agriculturally and petrochemically sourced oils and materials.

CEO Jens Klein expressed gratitude for the support of investors, emphasizing the importance of collaboration with nature in driving sustainable innovation. He highlighted the company's commitment to expanding its capacity to develop intrinsically sustainable materials that not only meet market demands but also contribute to a healthier planet.

In addition to existing investors, the Series A round welcomed new participants, including the corporate venture of global FMCG giant Henkel, Henkel dx Ventures, Bayern Kapital, and Alante Capital. Ted Persson, Partner at EQT Ventures, commended Insempra for its potential to revolutionize industrial manufacturing processes and gain rapid market traction with its innovative products.

Following an initial $15 million Seed round in 2021, this latest financing will support Insempra in scaling up its technology scouting, development, and manufacturing capabilities. With a focus on creating bio-based alternatives and sustainable solutions, Insempra is poised to lead the way in transforming industries and reducing our environmental footprint.

As we look towards a more sustainable future, Insempra's commitment to innovation and collaboration with nature serves as a beacon of hope for a world where high-performance, sustainable ingredients are the norm rather than the exception. With the support of investors and a dedicated team, Insempra is well-positioned to drive positive change and shape the future of sustainable manufacturing.